Glomerulonephritis Pattern at a Jordanian Tertiary Care Center

Table 1

Distribution of glomerular diseases based on incidence and patients’ sex.

Diagnosis	Number ()	Male ()	Female ()	P value
Primary Glomerulonephritis
MGN	32 (15.3%)	20 (22.7%)	12 (9.9%)	0.018
IgAN	17 (8.1%)	9 (10.2%)	8 (6.6%)	0.244
FSGS	12 (5.7%)	8 (9.1%)	4 (3.3%)	0.071
MCD	10 (4.8%)	6 (6.8%)	4 (3.3%)	0.198
MesPGN	9 (4.3%)	5 (5.7%)	4 (3.3%)	0.309
MPGN	9 (4.3%)	2 (2.3%)	7 (5.8%)	0.189
Chronic GN	9 (4.3%)	7 (8.0%)	2 (1.7%)	0.189
Post infectious GN	4 (1.9%)	3 (3.4%)	1 (0.8%)	0.202
Alport disease	1 (0.5%)	1 (1.1%)	0	0
CGN	4 (1.9%)	2 (2.3%)	2 (1.7%)	1
Secondary Glomerulonephritis
Lupus nephritis	70 (33.5%)	10 (11.4%)	60 (49.6%)	< .001
Diabetic nephropathy	23 (11.0%)	11 (12.5%)	12 (9.9%)	0.355
Fibrillary	5 (2.4%)	2 (2.3%)	3 (2.5%)	0.647
Renal amyloidosis	4 (1.9%)	3 (3.4%)	1 (0.8%)	0.202
Total	209 (100%)	88 (42.1%)	121 (57.9%)

Statistically significant difference. FSGS: focal and segmental glomerulosclerosis; MGN: membranous glomerulonephritis; IgAN: IgA nephropathy; MPGN: membranoproliferative glomerulonephritis; CGN: crescentic glomerulonephritis; MCD: minimal change disease; MesPGN: mesangioproliferative glomerulonephritis; GN: glomerulonephritis.